Amyotrophic lateral sclerosis (ALS).
暂无分享,去创建一个
[1] L. Ronnevi,et al. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis , 1976, Journal of the Neurological Sciences.
[2] R. Bergh,et al. Adipose tissue cellularity in patients with amyotrophic lateral sclerosis , 1978, Clinical Neurology and Neurosurgery.
[3] M. Klein,et al. Ethyl apovincaminate therapy in neurovascular diseases. , 1976, Arzneimittel-Forschung.
[4] E. Kárpáti,et al. Protective activity of ethyl apovincaminate on ischaemic anoxia of the brain. , 1976, Arzneimittel-Forschung.
[5] F. Túry,et al. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF. , 1976, Arzneimittel-Forschung.
[6] T. Chase,et al. Endocrinologic regulation of carbohydrate metabolism. Amyotrophic lateral sclerosis and Parkinsonism-dementia on Guam. , 1979, Archives of neurology.
[7] L. Weiner. Possible role of androgen receptors in amyotrophic lateral sclerosis. A hypothesis. , 1980, Archives of neurology.
[8] F. Solti,et al. Effect of ethyl apovincaminate on the cerebral circulation. Studies in patients with obliterative cerebral arterial disease. , 1976, Arzneimittel-Forschung.